老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

18.09
-0.5200-2.79%
盘后：18.090.00000.00%16:10 EDT
成交量：162.16万
成交额：2,940.76万
市值：20.08亿
市盈率：-11.29
高：18.72
开：18.39
低：17.82
收：18.61
52周最高：44.34
52周最低：15.96
股本：1.11亿
流通股本：1.09亿
量比：2.65
换手率：1.48%
股息：- -
股息率：- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
净资产收益率：-22.56%
总资产收益率：-12.16%
市净率：2.81
市盈率(LYR):-11.29

数据加载中...

总览公司新闻资讯公告
2020/06/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/29

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多